Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

There are numerous causes of memory and thinking difficulties ... The FDA has since approved three drugs for the treatment of mild to moderate AD: Donepezil (Aricept) was approved in 1996, ...

These ads make many claims about what nootropics can do for your brain, like increasing your memory, boosting your ... nootropics known as “smart drugs.” Hill says, "Examples of synthetic ...

Dementia treatment is more than just medication ... involved in learning and memory. Common cholinesterase inhibitors include: glantamine (Razadyne) donepezil (Aricept) rivastigmine (Exelon ...

Memory impairment can also be caused by poor ... turmoil of finding out he had the disease. He’s taking the drug donepezil to treat his symptoms. He has also joined a support group, is trying ...

Cholinesterase inhibitors are used in all stages of AD. These include donepezil (Aricept), rivastigmine (Exelon) and galantamine (Razadyne). These medications are prescribed to treat symptoms related ...

Statins, which are taken by people at risk of heart disease, could cause memory loss as a side-effect. Two new studies suggest that the drugs, which will soon be available over the counter ...

Nov. 6, 2024 — A new study changes the way we understand memory. Until now, memories have been explained by the activity of brain cells called neurons that respond to learning events and control ...

Scientists have discovered a new drug that could blast toxic protein ... starve brain cells of nutrients and slow down signals in the organ with memory and thinking ability becoming increasingly ...

However, a person's memory will fluctuate at this stage ... taking the medications they took at previous stages, like donepezil, or drugs for middle to later stages, such as memantine (Namenda).

Investors are worried that a huge production increase from China could derail the recovery of the memory-chip market. That doesn’t yet seem like an immediate risk, but China could still be a ...